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DMD Duchenne muscular dystrophy
NIV Non-invasive ventilation
PAQ-C/A Physical Activity Questionnaire
for Children and Adolescents
PedsQL
MFS
Pediatric Quality of Life Inventory
Multidimensional Fatigue Scale
AIM To describe fatigue in Duchenne muscular dystrophy (DMD) from patients’ and parents’
perspectives and to explore risk factors for fatigue in children and adolescents with DMD.
METHOD A multicentre, cross-sectional study design was used. Seventy-one patients (all
males; median age 12y, age range 5–17y) identified via the Canadian Neuromuscular Disease
Registry, and their parents completed questionnaires. Subjective fatigue was assessed using
the Pediatric Quality of Life Inventory Multidimensional Fatigue Scale by child self-report and
parent proxy-report.
RESULTS Patients with DMD across ages and disease stages experienced greater fatigue
compared to typically developing controls from published data. Sleep disturbance symptoms
were associated with greater fatigue by child self-report (q=–0.42; p=0.003) and parent proxy-
report (q=–0.51; p<0.001). Depressive symptoms were associated with greater fatigue by child
self-report (q=–0.46; p<0.001) and parent proxy-report (q=–0.45; p<0.001). Lower functional ability
was associated with greater fatigue by parent proxy-report (q=0.26; p=0.03). Physical activity
level, and musculoskeletal, respiratory, and cardiac function were not associated with fatigue.
INTERPRETATION In paediatric DMD, sleep disturbance symptoms and depressive symptoms
are potentially modifiable factors associated with fatigue, warranting additional investigation
to facilitate the development of therapeutic strategies to reduce fatigue.
Duchenne muscular dystrophy (DMD) is an X-linked
recessive disease characterized by the absence of, or defect
in, the sarcolemma protein dystrophin, resulting in pro-
gressive muscle degeneration and loss of ambulation.
Additional musculoskeletal, respiratory, and cardiac com-
plications emerge as DMD advances.1 Children and ado-
lescents with DMD are at increased risk of developmental,
emotional, and behavioural problems.2 Improved manage-
ment with corticosteroid therapy and non-invasive ventila-
tion (NIV) has prolonged survival. There is no cure for
DMD; therapeutic strategies aim to delay disease progres-
sion and improve quality of life.1 Fatigue recently emerged
as the strongest predictor of poor health-related quality of
life in children and adolescents with DMD, from both
patients’ and caregivers’ perspectives.3
Subjective fatigue, the focus of this study, is defined as a
lack of energy or the existence of weakness or exhaustion —
mentally, physically, or both.4 Subjective fatigue differs
from physiological fatigue or fatigability, which refer to
difficulty maintaining physical or mental activity at a
desired level.5 In neuromuscular disorders, physiological
fatigue is related to functioning of the central or peripheral
nervous system (lower motor neuron, neuromuscular junc-
tion, or muscle), and assessed objectively in a laboratory
setting.5 Subjective fatigue is ideally assessed using
validated standardized questionnaires addressing the
patient perspective.
Fatigue is frequent and among the most disabling symp-
toms in adult neuromuscular disorders, but it is not well
characterized in paediatric neuromuscular disorders,
including DMD. Fatigue may limit children’s participation
in age-related recreational and school activities, and conse-
quently delay development, which is already problematic in
children and adolescents with DMD. This may, in turn,
ultimately impact social, educational, and occupational
pursuits during adulthood.6
Data on mechanisms, prevention, and management of
fatigue in neuromuscular disorders and paediatric chronic
health conditions are limited, with most studies of the lat-
ter population focusing on childhood cancer.7,8 To our
knowledge, no study has explored factors associated with
fatigue in DMD. Therefore, identifying fatigue and under-
standing its determinants may facilitate the development of
therapeutic strategies to reduce fatigue and improve
health-related quality of life.
To facilitate best clinical practice for the prevention and
management of fatigue in children and adolescents with
DMD, an understanding of patients’ and parents’ perspec-
tives of fatigue is needed. Parents’ perceptions of their
child’s health influences healthcare utilization — particularly
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when the child is too young, too cognitively impaired, or too
ill to self-manage his or her own health.9 This study aimed
to describe fatigue in DMD from patients’ and parents’
perspectives, and to explore associations of patient charac-
teristics with child/adolescent self-reported and parent
proxy-reported fatigue.
METHOD
A multicentre cross-sectional study design was used. Eligi-
ble patients were identified via the Canadian Neuromuscu-
lar Disease Registry (CNDR), a clinic-based registry that
includes patients from nine paediatric neuromuscular clin-
ics across Canada.10 Data were collected using mailed
paper questionnaires and registry data collected at patients’
routine clinic visits. Eligible patients and their primary
caregivers were sent questionnaires between July 2016 and
November 2016. Patients and parents were instructed to
complete their respective questionnaires independently. If
a patient was unable to complete their questionnaire inde-
pendently, the parent was instructed to read the questions
to the patient verbatim without providing interpretation,
and to indicate the patient’s answers on the questionnaire
without providing guidance on how to respond. Parents of
young children were instructed to act as interviewers for
their child. A four-contact mailing strategy was used to
maximize the response rate in accordance with the Tai-
lored Design Method.11 Patient clinical characteristics
were retrieved from the CNDR database. Implied consent
was assumed for patients and parents who returned com-
pleted questionnaires.
Approval for the study was obtained from the Research
Ethics Board at Western University and the CNDR.
Participants
Eligible patients were identified according to the following
inclusion criteria: (1) patients have consented, or a parent
or guardian has consented on their behalf, to be notified
by the CNDR of research opportunities; (2) patients with
a DMD diagnosis confirmed by genetic testing or muscle
biopsy, and clinical presentation consistent with DMD; (3)
patients are males; (4) patients are between 5 and 17 years
of age; and (5) patients have a primary caregiver available
to complete a parent questionnaire. Patients were ineligible
according to the following exclusion criteria: (1) both
patient and parent were unable to complete questionnaires,
even with assistance, due to limited literacy, a communica-
tion disorder, or cognitive impairment; and (2) patient has
a comorbidity unrelated to DMD, which may influence
study outcomes.
Measures
Age, musculoskeletal characteristics (ambulatory status,
wheelchair use, scoliosis status, corticosteroid therapy sta-
tus), respiratory characteristics (forced vital capacity, venti-
latory status), and cardiac characteristics (left ventricular
ejection fraction) were retrieved from the CNDR database.
Fatigue, physical activity level, functional ability related to
activities of daily living, depressive symptoms, and sleep dis-
turbance symptoms were assessed using survey measures.
Fatigue was measured using the Pediatric Quality of Life
Inventory (PedsQL) Multidimensional Fatigue Scale (MFS)
by child self-report and parent proxy-report. Parent proxy-
report forms are parallel to child self-report forms and
assess parents’ perceptions of their child’s fatigue. The
PedsQL MFS is composed of three domains: General Fati-
gue (six items, e.g. ‘I feel tired’; ‘I feel too tired to do
things that I like to do’), Sleep/Rest Fatigue (six items, e.g.
‘I feel tired when I wake up in the morning’), and Cogni-
tive Fatigue (six items; e.g. ‘It is hard for me to keep my
attention on things’; ‘It is hard for me to think quickly’).
Respondents were asked to indicate how much of a prob-
lem each item had been in the past month. A total score
and domain scores were computed, each ranging from 0 to
100, with higher scores indicating less fatigue due to
reverse scoring. Total scores were computed if 50% or
more items were completed. Domain scores were com-
puted if 50% or more items were completed within each
domain.9 PedsQL MFS scores of our sample were com-
pared with scores of typically developing children derived
from a previous study.12 Data exclusively on typically
developing males aged 5 to 17 years were provided by the
developers of the PedsQL MFS and authors of the previ-
ously published study12 for our comparison.
Physical activity level was assessed by child self-report
using an adapted Physical Activity Questionnaire for Chil-
dren and Adolescents (PAQ-C/A). The PAQ-C/A was
adapted such that all items were applicable to ambulant
and non-ambulant patients with DMD. Respondents were
instructed to consider any activity that causes them to
sweat, breathe hard, or causes their legs or arms to feel
tired. The PAQ-C/A measures physical activity level dur-
ing the past 7 days. PAQ-C/A scores range from 1 (low
physical activity) to 5 (high physical activity).13 In the case
of missing items, a score was not computed.
Functional ability related to activities of daily living was
assessed by parent proxy-report using the DMD Func-
tional Ability Self-Assessment Tool, which assesses physical
and respiratory functioning at all disease stages in patients
with DMD. Respondents were asked to rate their current
level of functioning in relation to common activities of
daily living, upper and lower extremities, and ventilation
status. DMD Functional Ability Self-Assessment Tool
scores range from 0 (low functional ability) to 23 (high
functional ability).14 In the case of missing items, a total
score was computed by dividing the sum of completed
items by the maximum possible score of completed items,
and multiplying this fraction by the maximum possible
score of all items.
What this paper adds
• Fatigue is a major issue in paediatric Duchenne muscular dystrophy (DMD)
across ages and disease stages.
• Sleep disturbance and depressive symptoms are significantly associated with
fatigue in paediatric DMD.
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Depressive symptoms were assessed by child self-report
using the Center for Epidemiological Studies Depression
Scale for Children. Respondents were asked to indicate how
strongly they experienced certain feelings during the past
week. The Center for Epidemiological Studies Depression
Scale for Children scores range from 0 to 60, with higher
scores indicating more depressive symptoms.15 In the case of
missing items, a total score was computed after imputing the
mean of completed items as the response for missing items.
Sleep disturbance symptoms were assessed by parent
proxy-report using the Sleep Disturbance Scale for Chil-
dren, which is composed of six domains: disorders of initi-
ating and maintaining sleep, sleep-related breathing
disorders, disorders of arousal, sleep–wake transition disor-
ders, disorders of excessive somnolence, and sleep hyper-
hidrosis. Respondents were asked to consider their child’s
sleep behaviour during the past 6 months. A total score
and domain scores were computed. Possible Sleep Distur-
bance Scale for Children total scores range from 26 to
130, with higher scores indicating more sleep disturbance
symptoms.16 In the case of missing items, the total and
domain scores were not computed.
Statistical analysis
For patient characteristics, median and interquartile range
(IQR) were computed for continuous variables, and fre-
quencies and percentages were computed for categorical
variables. Mean and standard deviations (SD) or median
and IQR were computed for child self-report and parent
proxy-report PedsQL MFS scores. Associations between
child self-reports and parent proxy-reports of PedsQL
MFS scores were examined using pairwise correlation anal-
yses with Spearman’s rank correlation coefficient.
Bivariate analyses were conducted to explore associations
of patient characteristics with child self-reported and par-
ent proxy-reported fatigue. Associations of continuous vari-
ables with PedsQL MFS scores were examined using
pairwise correlation analyses with Spearman’s rank correla-
tion coefficient. For dichotomous variables, unpaired two-
sample t-tests or Mann–Whitney U test were used to assess
differences in PedsQL MFS scores between categories. For
categorical variables of more than two categories, one-way
analysis of variance (ANOVA) or Kruskal–Wallis tests were
used to assess differences in PedsQL MFS scores between
categories. Bivariate analyses were performed using pair-
wise deletion. Exploratory multivariable linear regression
analyses were used to explore the adjusted associations of
patient characteristics with child self-reported and parent
proxy-reported fatigue. Multivariable analyses were per-
formed using complete case analysis (listwise deletion).
Statistical analyses were performed using Stata version
13.0 (StataCorp LP, College Station, TX, USA). A two-
sided level of significance at p=0.05 was assumed.
RESULTS
Of 193 eligible participants identified and sent ques-
tionnaires, 71 patient-parent pairs returned completed
questionnaires. Both patient and parent questionnaires
were completed by 64 patient–parent pairs, while for five
participants only the parent questionnaire was completed
and for two participants only the patient questionnaire was
completed. Patient clinical characteristics for participants
and non-participants are summarized in Table I. Partici-
pating and non-participating patients were similar with
respect to age and musculoskeletal, respiratory, and cardiac
characteristics, including scoliosis and invasive ventilation
(data not presented). The ratio of ambulant to non-ambu-
lant patients was lower for participating patients compared
to non-participating patients.
Descriptive statistics for PedsQL MFS scores are pre-
sented in Table II, along with PedsQL MFS scores of typ-
ically developing males for comparison.12 Males with
DMD experienced greater fatigue (lower scores) compared
with typically developing peers from published data across
domains, by child self-report and parent proxy-report.12
Mean (SD) age of typically developing males was 12 years
11 months (3y 2mo) and ranged from 5 to 17 years.
PedsQL MFS scores by child self-report were significantly
associated with PedsQL MFS scores by parent proxy-
report: total fatigue (q=0.69; p<0.001), general fatigue
(q=0.63; p<0.001), sleep/rest fatigue (q=0.50; p<0.001), and
cognitive fatigue (q=0.68; p<0.001).
Correlation analysis between continuous variables and
PedsQL MFS scores by child self-report and parent
proxy-report are presented in Tables III and IV respec-
tively. Scatter plots of total fatigue versus physical activity
level, functional ability, depressive symptoms, and sleep
disturbance symptoms can be seen in Figures S1 to S8
Table I: Comparison of clinical characteristics retrieved from the






Age, y 12 (9–15) 12 (10–14)
Musculoskeletal characteristics
Unsupported ambulation
Ambulant 42 (59) 84 (69)
Non-ambulant 28 (39) 31 (25)
Wheelchair use
Never 30 (42) 47 (39)
Intermittent 16 (23) 38 (31)
Permanent 17 (24) 27 (22)
Corticosteroid therapy
Never 9 (13) 8 (7)
Past 1 (1) 2 (2)
Current 52 (73) 101 (83)
Respiratory characteristics
Forced vital capacity 88 (72–99) 82.5 (67–94.5)
Non-invasive ventilatory support
No 66 (93) 105 (86)
Part-time 2 (3) 6 (5)




64 (60–67.2) 63.9 (59.5–68.5)
Data are frequency (%) or median (IQR).
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(online supporting information). Greater physical activity
level was significantly associated with greater general fati-
gue by child self-report. Lower functional ability was sig-
nificantly associated with greater general fatigue by child
self-report, and with greater total fatigue, general fatigue,
and sleep/rest fatigue by parent proxy-report. More depres-
sive symptoms were significantly associated with greater
total fatigue, general fatigue, sleep/rest fatigue, and cogni-
tive fatigue by child self-report and parent proxy-report.
More total sleep disturbance symptoms were significantly
associated with greater total fatigue, general fatigue, sleep/
rest fatigue, and cognitive fatigue by child self-report and
parent proxy-report. Significant correlations with fatigue
were most frequently observed for disorders of initiating
and maintaining sleep, disorders of arousal, sleep/wake
transition disorders, and disorders of excessive somnolence
(Tables SI and SII, online supporting information).
Parent proxy-reported sleep/rest fatigue was greater for
patients treated with part-time NIV compared with patients
not treated with NIV, as demonstrated by Kruskal–Wallis
test (v2=7.02; df=2; p=0.03), followed by post hoc analysis
using Dunn’s test (p=0.03).17 NIV status was not associated
with other domains of fatigue (data not presented). Muscu-
loskeletal characteristics (ambulatory status, wheelchair use,
scoliosis status, corticosteroid therapy status) were not asso-
ciated with fatigue (data not presented).
Because bivariate analyses did not consistently demon-
strate significant associations between objective measures
of musculoskeletal, respiratory, and cardiac function and
fatigue, overall functional ability may be more related to
fatigue than any single musculoskeletal, respiratory, or car-
diac characteristic. Thus, functional ability measured using
the DMD Functional Ability Self-Assessment Tool was
included as a covariate in the multivariable linear regres-
sion analyses, rather than single measures of musculo-
skeletal, respiratory, and cardiac function.
Multivariable analyses (n=41) demonstrated that physical
activity level, functional ability, depressive symptoms, and
sleep disturbance symptoms explained 38% of the variabil-
ity in child self-reported total fatigue and 44% of the vari-
ability in parent proxy-reported total fatigue. Physical
activity level was not associated with total fatigue by
child self-report (b=2.50; p=0.37) or parent proxy-report
(b=–1.37; p=0.61), while adjusting for functional ability,
depressive symptoms, and sleep disturbance symptoms.
Functional ability was significantly associated with greater
total fatigue by parent proxy-report (b=0.68; p=0.03), but
not child self-report (b=–0.18; p=0.57), while adjusting for
physical activity level, depressive symptoms, and sleep dis-
turbance symptoms. Depressive symptoms were not associ-
ated with total fatigue by child self-report (b=–0.32;
p=0.31) or parent proxy-report (b=–0.28; p=0.36), while
adjusting for physical activity level, functional ability, and
sleep disturbance symptoms. More sleep disturbance symp-
toms were significantly associated with greater total fatigue
by child self-report (b=–0.84; p=0.001) and parent proxy-
report (b=–0.91; p<0.001), while adjusting for physical
activity level, functional ability, and depressive symptoms.
Table II: Descriptive statistics for the Pediatric Quality of Life









66 69.4 (62.5–81.9) 71.6 (15.2) 110 82.6 (13.2)
General
fatigue
66 70.8 (58.3–83.3) 70.2 (19.7) 87.5 (14.4)
Sleep/rest
fatigue
66 75.0 (64.6–87.5) 74.0 (17.5) 76.9 (17.9)
Cognitive
fatigue




69 69.4 (58.3–84.7) 70.8 (16.0) 121 88.3 (11.6)
General
fatigue
69 62.5 (45.8–79.2) 64.2 (20.1) 88.8 (13.6)
Sleep/rest
fatigue
69 79.2 (66.7–91.7) 76.9 (18.0) 87.8 (14.5)
Cognitive
fatigue
69 75.0 (54.2–91.7) 69.7 (24.6) 88.1 (15.3)
DMD, Duchenne muscular dystrophy.
Table III: Correlation analyses between child characteristics and Pediatric Quality of Life Inventory Multidimensional Fatigue Scale scores by child









Age, y 0.01 (66) –0.19 (65) –0.06 (66) 0.23 (66)
Forced vital capacity 0.29 (40) 0.34a (39) 0.15 (40) 0.03 (40)
Left ventricular ejection fraction 0.00 (42) 0.10 (41) –0.22 (42) 0.08 (42)
Child self-report or parent proxy-report measures
Physical Activity Questionnaire for Children and Adolescents 0.13 (58) 0.27a (57) 0.12 (58) –0.06 (58)
Duchenne Muscular Dystrophy Functional Ability Self-Assessment Tool 0.05 (64) 0.30a (63) -0.01 (64) –0.13 (64)
Center for Epidemiological Studies Depression Scale for Children –0.46b (66) –0.30a (65) -0.30a (66) –0.46b (66)
Sleep Disturbance Scale for Children –0.42a (46) –0.32a (45) –0.30a (46) –0.33a (46)
Data are q (n). ap<0.05; bp<0.001.
248 Developmental Medicine & Child Neurology 2020, 62: 245–251
DISCUSSION
To our knowledge, this is the first study to describe fatigue
and to identify factors associated with fatigue in paediatric
DMD across the full spectrum of ages and disease stages
from patients’ and parents’ perspectives. Fatigue is a
prominent concern in children and adolescents with DMD,
highlighting the need for fatigue to be addressed in routine
care of affected males. Males with DMD experienced
greater fatigue than typically developing males in a previ-
ous study,12 from both patients’ and parents’ perspectives.
Child self-reported and parent proxy-reported fatigue
scores of males with DMD in our study were comparable
to previously published scores of a multicentre cohort of
ambulant males with DMD18, as well as scores of children
and adolescents with cancer, for whom fatigue is recog-
nized as a frequent and debilitating symptom.19
Of the patient characteristics explored in our study, sleep
disturbance symptoms and depressive symptoms emerged
as the strongest correlates of fatigue. Lower functional
ability was associated with greater fatigue from parents’
perspective only. Thus, parents may be more likely to per-
ceive their child’s fatigue as an outcome of, or contributor
to, the progressive functional decline associated with
DMD than patients themselves. Physical activity level and
clinical characteristics including age and musculoskeletal,
respiratory, and cardiac function were not consistently
associated with fatigue. These findings should be inter-
preted with caution, considering that fatigue may not
manifest as a symptom of musculoskeletal and cardiorespi-
ratory decline until the late ambulatory to non-ambulatory
stages, or in adulthood. Patients in our sample had rela-
tively preserved cardiorespiratory function.
Because sleep disturbances are frequent in paediatric
DMD, and variations exist in their assessment and manage-
ment in clinical practice, sleep disturbance symptoms may
be a modifiable factor associated with fatigue.20,21 More
sleep disturbance symptoms were associated with greater
fatigue from both patients’ and parents’ perspectives. Sleep-
related breathing disorders, of non-obstructive and obstruc-
tive origin, are common in DMD.20 In our study, symptoms
of sleep-related breathing disorders did not emerge as a
correlate of fatigue. However, the accuracy of parent
proxy-reported symptoms of sleep-related breathing disor-
ders compared with objective sleep measurements is
unclear.20 Moreover, symptoms such as restless sleep, night-
mares, morning confusion, and excessive daytime sleepiness
may be related to sleep-related breathing disorders, but were
scored as items of other domains in the Sleep Disturbance
Scale for Children.16 Thus, the lack of association between
sleep disordered breathing and fatigue should be interpreted
cautiously. Symptoms of disorders of initiating and main-
taining sleep, disorders of arousal, sleep-wake transition dis-
orders, and disorders of excessive somnolence demonstrated
the strongest associations with fatigue. Disorders of initiat-
ing and maintaining sleep and disorders of excessive somno-
lence are prevalent in an estimated 30% and 11% of males
with DMD respectively.20 Thus, clinical sleep evaluations in
males with DMD should not be limited to detecting sleep-
related breathing disorders.
Sleep evaluations in patients with DMD are recom-
mended as early as the ambulatory stage, or at the onset of
daytime symptoms of sleep disordered breathing or abnor-
mal pulmonary function tests.22 Because overnight pulse
oximetry with capnography has limited utility for detecting
sleep disturbances not associated with hypoxemia or hyper-
capnia, and because there is a poor correlation between
daytime symptoms, abnormal pulmonary function, and
sleep disturbances, a ‘polysomnography for all policy’ has
been proposed.23 Polysomnography is important for indi-
cating the need for timely intervention with NIV, which
can reduce symptoms of sleep disordered breathing and
potentially confer a beneficial effect on fatigue.
Sleep can be further complicated by disease-related, psy-
chological, and social factors. Muscle weakness and the need
to be turned by a caregiver during the night have been
reported to be associated with sleep disturbance symp-
toms.20 Emotional and behavioural problems also contribute
to sleep disturbance symptoms. Parental exhaustion, sleep
deprivation, and poor mental health associated with caring
for a child with DMD, can contribute to vulnerability of
families and interfere with development of effective sleep
hygiene practices in affected males. Recommendations for
the assessment and management of sleep disturbances in
DMD should be interdisciplinary and extend beyond sleep
Table IV: Correlation analyses between child characteristics and Pediatric Quality of Life Inventory Multidimensional Fatigue Scale scores by parent










Age, y 0.06 (69) –0.10 (69) –0.18 (69) 0.20 (69)
Forced vital capacity (%) 0.12 (40) 0.22 (40) 0.07 (40) –0.01 (40)
Left ventricular ejection fraction (%) 0.06 (41) 0.22 (41) –0.07 (41) 0.02 (41)
Child self-report or parent proxy-report measures
Physical Activity Questionnaire for Children and Adolescents 0.09 (57) 0.16 (57) 0.18 (57) –0.11 (57)
Duchenne Muscular Dystrophy Functional Ability Self-Assessment Tool 0.26a (69) 0.30a (69) 0.3a (69) 0.08 (69)
Center for Epidemiological Studies Depression Scale for Children –0.45b (64) –0.37a (64) –0.35a (64) –0.32a (64)
Sleep Disturbance Scale for Children –0.51b (50) –0.45a (50) –0.48a (50) –0.34a (50)
Data are q (n). ap<0.05; bp<0.001.
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disordered breathing to include other sleep disorders, as well
as disease-related, psychological, and social factors.
Consistent with findings in other paediatric patient pop-
ulations,24 our results demonstrated more depressive symp-
toms were associated with greater fatigue in males with
DMD from patients’ and parents’ perspectives. Males
with DMD are at increased risk of depression compared
with their typically developing peers or other paediatric
patient populations with physical disabilities.25 In a cross-
sectional study of adults with DMD, fatigue and affective
disorders coexisted in 24% of patients.26
Fatigue, sleep disturbance symptoms, and depressive
symptoms can occur independently, or coexist and exacer-
bate one another. Distinguishing fatigue from sleep distur-
bance symptoms and depressive symptoms, and
understanding causal relationships of this triad is essential
for developing targeted therapeutic strategies to achieve
satisfactory outcomes. Fatigue implies mental or physical
exhaustion, independent of exertion or amount of sleep,
whereas excessive daytime sleepiness implies a problem
with the sleep–wake cycle.6 Depression is characterized by
a general lack of interest in daily activities that are typically
enjoyed; however, this motivational component is unaf-
fected in fatigue.27
Because we used a cross-sectional study design, multi-
variable regression analyses do not allow for conclusions
about directionality to be made, but serve to explore
adjusted associations between related factors and fatigue.
Fatigue, sleep disturbance symptoms, and depressive symp-
toms have complex bidirectional relationships. Despite a
strong association between depression and fatigue, causal
relationships between depression and fatigue remain to be
elucidated in longitudinal studies.28
Physical activity level was not associated with fatigue in
males with DMD, in contrast to previous findings whereby
physical inactivity was associated with fatigue in children
and adolescents with physical disabilities.29 It is possible
that the PAQ-C/A did not adequately capture variability in
physical activity level of males with DMD, reducing the
magnitude of association between physical activity level
and fatigue. Because most measures of physical activity
level are intended for use in typically developing children,
there is a need to develop feasible, valid, and reliable mea-
sures for use in patients with neuromuscular disorders,
which quantify lower and upper limb activity.
The following limitations of our study should be consid-
ered when interpreting the results. The cross-sectional
study design does not allow for temporality or causality of
associations to be established. Lack of statistical power
may have resulted in failure to detect associations between
clinical characteristics and fatigue. It is unclear whether
participants differ from non-participants with respect to
survey measures, or whether males enrolled in the CNDR
systematically differ from affected males not enrolled in
the CNDR with respect to clinical characteristics or care
practices. Nevertheless, the use of a national registry facili-
tated the inclusion of patients from multiple clinics and
regions within Canada, enhancing generalizability. Because
questionnaires were not completed in a supervised setting,
we cannot be certain that patients and parents indepen-
dently completed their respective questionnaires.
Our findings contribute to the limited literature on fati-
gue in paediatric neuromuscular disorders. We identified
fatigue to be a prominent issue in paediatric DMD,
emphasizing the need for healthcare providers to become
more familiar with fatigue in this population and to engage
in dialogue about fatigue with patients and caregivers. We
identified sleep disturbance symptoms and depressive
symptoms to be associated with fatigue in paediatric
DMD, contributing to our understanding of the subjective
experience of fatigue as a complex, multi-causal, and multi-
dimensional phenomenon. Sleep disturbance symptoms
and depressive symptoms may be overlooked in routine
management of children and adolescents with DMD, war-
ranting further investigation as potentially modifiable risk
factors for fatigue in this population. Child self-report and
parent proxy-report symptom-based measures are easy to
administer and are associated with a low participation bur-
den. However, measures of sleep disturbance symptoms
and depressive symptoms provide limited information on
the associations of formal diagnoses of sleep disturbances
and depression with fatigue. To further understand these
relationships, polysomnographic data and psychiatric evalu-
ations conducted by clinicians are required in future stud-
ies. Prospective cohort studies are required to establish
causality between patient characteristics and fatigue, to
facilitate the development of targeted therapeutic strategies
to reduce fatigue, and to improve health-related quality of
life. Qualitative studies can also provide insight into the
origin, severity, patterns, and impact of fatigue.
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SUPPORTING INFORMATION
The following additional material may be found online:
Figure S1: Relationship between physical activity level and
total fatigue by child self-report
Figure S2: Relationship between functional ability and total
fatigue by child self-report
Figure S3: Relationship between depressive symptoms and
total fatigue by child self-report
Figure S4: Relationship between sleep disturbance symptoms
and total fatigue by child self-report
Figure S5: Relationship between physical activity level and
total fatigue by parent proxy-report
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Figure S6: Relationship between functional ability and total
fatigue by parent proxy-report
Figure S7: Relationship between depressive symptoms and
total fatigue by parent proxy-report
Figure S8: Relationship between sleep disturbance symptoms
and total fatigue by parent proxy-report
Table SI: Correlation analyses between sleep disturbance
symptoms and Pediatric Quality of Life Inventory Multidimen-
sional Fatigue Scale scores by child self-report
Table SII: Correlation analyses between sleep disturbance
symptoms and Pediatric Quality of Life Inventory Multidimen-
sional Fatigue Scale scores by parent proxy-report
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RESUMEN
FATIGA EN JOVENES CON DISTROFIA MUSCULAR DE DUCHENNE
OBJETIVO Describir la fatiga en la distrofia muscular de Duchenne (DMD) desde la perspectiva de los pacientes y los padres, y
explorar los factores de riesgo de fatiga en ni~nos y adolescentes con DMD.
METODO Se utilizo un dise~no transversal, con informacion de diversos centros. En total 71 pacientes (todos varones; edad media
12 a~nos, rango de edad 5 a 17 a~nos) identificados a traves del Registro Canadiense de Enfermedades Neuromusculares, y sus
padres completaron cuestionarios. La fatiga subjetiva se evaluo utilizando la Escala de Fatiga Multidimensional del Inventario de
Calidad de Vida Pediatrica usando la informacion provista por los ni~nos y por los padres.
RESULTADOS Los pacientes con DMD en todas las edades y etapas de la enfermedad experimentaron una mayor fatiga en
comparacion con los datos publicados en grupo de ni~nos que que se desarrollan tıpicamente (controles). Los sıntomas de
alteracion del sue~no se asociaron con mayor fatiga reportada por el ni~no (q = –0,42; p = 0,003) y por los padres (q = –0,51; p
<0,001). Los sıntomas de depresion se asociaron con mayor fatiga reportada por el ni~no (q = –0,46; p <0,001) y por los padres (q =
–0,45; p <0,001). La capacidad funcional mas baja se asocio con mayor fatiga reportada por los padres (q = 0,26; p = 0,03). El nivel
de actividad fısica y la funcion musculoesqueletica, respiratoria y cardıaca no se asociaron con la fatiga.
INTERPRETACION En la DMD pediatrica, los sıntomas de alteracion del sue~no y los sıntomas de depresion son factores asociados
con la fatiga. Estos factores son potencialmente modificables, lo que justifica una investigacion adicional para facilitar el
desarrollo de estrategias terapeuticas para reducir la fatiga.
RESUMO
FADIGA EM JOVENS COM DISTROFIA MUSCULAR DE DUCHENNE
OBJETIVO Descrever a fadiga na distrofia muscular de Duchenne (DMD) pela perspectiva de pacientes e pais, e explorar fatores de
risco para fadiga em criancas e adolescentes com DMD.
METODO Um desenho de estudo multicêntrico e transversal foi usado. Setenta e um pacientes (todos do sexo masculino; idade
mediana 12a, variac~ao da idade 5–17a) identificados via Registro Canadense de Doencas Neuromusculares, e seus pais,
completaram os questionarios. A fadiga subjetiva foi avaliada usando a Escada de Fadiga do Inventario Pediatrico de Qualidade
de Vida Multidimensional por auto-relato da crianca e relato dos pais.
RESULTADOS Pacientes com DMD de varias idades e estagios da doenca apresentaram mais fadiga comparados os controles com
desenvolvimento tıpico de dados publicados. Sintomas de disturbios do sono foram associados com maior fadiga pelo auto-relato
das criancas (q=–0,42; p=0,003) e pelo relato dos pais (q=–0,51; p<0,001). Sintomas depressivos foram associados com maior
fadiga no auto-relato das criancas (q=–0,46; p<0,001) e pelo relato dos pais (q=–0,45; p<0,001). Menor capacidade funcional se
associou com maior fadiga de acordo com o relato dos pais (q=0,26; p=0,03). Nıvel de atividade fısica, e func~ao musculo-
esqueletica, respiratoria, e cardıaca n~ao foram associadas com a fadiga.
INTERPRETAC~AO Na DMD pediatrica, sintomas de disturbios do sono e sintomas depressivos s~ao fatores potencialmente
modificaveis, que merecem investigac~ao adicional para facilitar o desenvolvimento de estrategias terapêuticas para reduzir a
fadiga.
